Guoyi Ma

1.3k total citations
34 papers, 1.1k citations indexed

About

Guoyi Ma is a scholar working on Molecular Biology, Plant Science and Pharmacology. According to data from OpenAlex, Guoyi Ma has authored 34 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 8 papers in Plant Science and 6 papers in Pharmacology. Recurrent topics in Guoyi Ma's work include Bioactive Compounds and Antitumor Agents (5 papers), Microbial Natural Products and Biosynthesis (4 papers) and Natural product bioactivities and synthesis (4 papers). Guoyi Ma is often cited by papers focused on Bioactive Compounds and Antitumor Agents (5 papers), Microbial Natural Products and Biosynthesis (4 papers) and Natural product bioactivities and synthesis (4 papers). Guoyi Ma collaborates with scholars based in United States, Egypt and China. Guoyi Ma's co-authors include Shabana I. Khan, Ikhlas A. Khan, Larry Walker, David S. Pasco, Jamal Mustafa, Sashi G. Kasimsetty, Daneel Ferreira, Muntha K. Reddy, Dobrosława Białońska and Premalatha Balachandran and has published in prestigious journals such as Environmental Science & Technology, Journal of Agricultural and Food Chemistry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Guoyi Ma

34 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guoyi Ma United States 17 375 265 205 198 152 34 1.1k
Sunil Kumar Mishra India 21 419 1.1× 283 1.1× 130 0.6× 165 0.8× 100 0.7× 92 1.5k
Eun‐Jung Park United States 23 544 1.5× 343 1.3× 271 1.3× 198 1.0× 67 0.4× 53 1.5k
Abuzer Ali Saudi Arabia 22 420 1.1× 236 0.9× 310 1.5× 168 0.8× 59 0.4× 121 1.5k
Supreeya Yuenyongsawad Thailand 18 263 0.7× 202 0.8× 249 1.2× 289 1.5× 108 0.7× 38 971
Alexandre Maciuk France 21 603 1.6× 326 1.2× 161 0.8× 138 0.7× 59 0.4× 83 1.5k
T. Sivakumar India 16 289 0.8× 416 1.6× 114 0.6× 124 0.6× 60 0.4× 91 1.0k
Raphaë͏l Grougnet France 19 509 1.4× 355 1.3× 165 0.8× 110 0.6× 47 0.3× 68 1.2k
Kok Wai Lam Malaysia 21 479 1.3× 170 0.6× 435 2.1× 208 1.1× 64 0.4× 84 1.4k
Shaza M. Al‐Massarani Saudi Arabia 19 327 0.9× 422 1.6× 95 0.5× 123 0.6× 71 0.5× 54 1.3k
Mohd Rais Mustafa Malaysia 16 396 1.1× 308 1.2× 120 0.6× 205 1.0× 74 0.5× 18 1.4k

Countries citing papers authored by Guoyi Ma

Since Specialization
Citations

This map shows the geographic impact of Guoyi Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guoyi Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guoyi Ma more than expected).

Fields of papers citing papers by Guoyi Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guoyi Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guoyi Ma. The network helps show where Guoyi Ma may publish in the future.

Co-authorship network of co-authors of Guoyi Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Guoyi Ma. A scholar is included among the top collaborators of Guoyi Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guoyi Ma. Guoyi Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wilkinson, Shane R., et al.. (2023). Systematic study of 1,2,3-triazolyl sterols for the development of new drugs against parasitic Neglected Tropical Diseases. European Journal of Medicinal Chemistry. 254. 115378–115378. 4 indexed citations
2.
Zhang, Teng, Guoliang Wang, Guoyi Ma, et al.. (2021). Epidemiological Characteristics of Influenza A and B in Macau, 2010–2018. Virologica Sinica. 36(5). 1144–1153. 3 indexed citations
3.
Pandey, Pankaj, Kuldeep K. Roy, Haining Liu, et al.. (2018). Structure-Based Identification of Potent Natural Product Chemotypes as Cannabinoid Receptor 1 Inverse Agonists. Molecules. 23(10). 2630–2630. 11 indexed citations
4.
Metwaly, Ahmed M., Frank R. Fronczek, Guoyi Ma, et al.. (2014). Antileukemic α-pyrone derivatives from the endophytic fungus Alternaria phragmospora. Tetrahedron Letters. 55(24). 3478–3481. 30 indexed citations
5.
Ghoneim, Mohammed M., et al.. (2013). Biologically Active Secondary Metabolites from Asphodelus Microcarpus. Natural Product Communications. 8(8). 1117–9. 27 indexed citations
6.
He, Yangqing, Guoyi Ma, Jiangnan Peng, Zhanying Ma, & Mark T. Hamann. (2012). Liver X receptor and peroxisome proliferator-activated receptor agonist from Cornus alternifolia. Biochimica et Biophysica Acta (BBA) - General Subjects. 1820(7). 1021–1026. 15 indexed citations
7.
Ma, Guoyi, et al.. (2010). Effects of Synephrine andβ-Phenethylamine on Humanα-Adrenoceptor Subtypes. Planta Medica. 76(10). 981–986. 34 indexed citations
8.
Ma, Guoyi, Chong Li, Xing‐Cong Li, et al.. (2010). Selective inhibition of human leukemia cell growth and induction of cell cycle arrest and apoptosis by pseudolaric acid B. Journal of Cancer Research and Clinical Oncology. 136(9). 1333–1340. 26 indexed citations
9.
Ma, Guoyi, et al.. (2008). Anticancer activities of sesquiterpene lactones from Cyathocline purpurea in vitro. Cancer Chemotherapy and Pharmacology. 64(1). 143–152. 36 indexed citations
10.
Mizuno, Cássia S., Guoyi Ma, Shabana I. Khan, et al.. (2008). Design, synthesis, biological evaluation and docking studies of pterostilbene analogs inside PPARα. Bioorganic & Medicinal Chemistry. 16(7). 3800–3808. 38 indexed citations
11.
Ma, Guoyi, Nurhayat Tabanca, K. Hüsnü Can Başer, et al.. (2008). Inhibition of NF-κB-mediated transcription and induction of apoptosis in human breast cancer cells by epoxypseudoisoeugenol-2-methyl butyrate. Cancer Chemotherapy and Pharmacology. 63(4). 673–680. 9 indexed citations
12.
Ma, Guoyi, et al.. (2007). Pharmacological Effects of Ephedrine Alkaloids on Human α1- and α2-Adrenergic Receptor Subtypes. Journal of Pharmacology and Experimental Therapeutics. 322(1). 214–221. 67 indexed citations
13.
Tabanca, Nurhayat, Guoyi Ma, David S. Pasco, et al.. (2007). Effect of essential oils and isolated compounds from Pimpinella species on NF‐κB: a target for antiinflammatory therapy. Phytotherapy Research. 21(8). 741–745. 32 indexed citations
14.
Balachandran, Premalatha, Nirmal D. Pugh, Guoyi Ma, & David S. Pasco. (2006). Toll-like receptor 2-dependent activation of monocytes by Spirulina polysaccharide and its immune enhancing action in mice. International Immunopharmacology. 6(12). 1808–1814. 93 indexed citations
15.
Ma, Guoyi, Shabana I. Khan, Gloria A. Benavides, et al.. (2006). Inhibition of NF-κB-mediated transcription and induction of apoptosis by melampolides and repandolides. Cancer Chemotherapy and Pharmacology. 60(1). 35–43. 32 indexed citations
16.
Ma, Guoyi, et al.. (2006). Tethered Yohimbine Analogs as Selective Human α2C-Adrenergic Receptor Ligands. Journal of Pharmacology and Experimental Therapeutics. 319(2). 739–748. 5 indexed citations
17.
Ma, Guoyi, et al.. (2005). Synthesis and biological studies of yohimbine derivatives on human α2C-adrenergic receptors. Bioorganic & Medicinal Chemistry Letters. 15(11). 2758–2760. 7 indexed citations
18.
Rong, Huang, et al.. (2003). Constituents of Volatile Oil and Cytotoxicity on Cyathocline purpurea. Plant Diversity. 25(4). 1. 2 indexed citations
19.
Luo, Lei, et al.. (2003). FLAVONOIDS FROM HYPERICUM SUBSESSILE. Tianran chanwu yanjiu yu kaifa. 15(4). 1 indexed citations
20.
Luo, Lei, et al.. (2003). A new bridged ring compound from Hypericum bellum. Acta Botanica Yunnanica. 25(5). 620–624. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026